Business / Finance

RSS

BioDelivery Sciences secures additional $20.7M in gross debt funding from MidCap Financial

BioDelivery Sciences International, Inc. announced today that it has secured an additional $20.7 million in gross debt funding from MidCap Financial to bring BDSI's total outstanding debt with MidCap to $30 million in a single senior secured loan.

1 Jun 2015

Self Service News names Pharmabox as one of the most innovative retailing systems of the year

Pharmabox, Inc.,, the developer of a unique automated drugstore, announced today they have been named by Self Service News Magazine as having one of the most innovative retailing systems of the year.

1 Jun 2015

BioLight Life Sciences reports operational and financial results for Q1 2015

BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the first quarter ended March 31, 2015.

1 Jun 2015

Actavis acquires Auden Mckenzie

Actavis plc today announced that it has completed its acquisition of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK.

1 Jun 2015

BiondVax provides update on financial results for first quarter 2015

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced its financial results for the first quarter of 2015 and provided a business update.

1 Jun 2015

HarkerBIO, AMRI sign collaborative agreement to market structure-based drug discovery services

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients.

1 Jun 2015

New study on best practices in developing top-tier medical affairs capabilities

The changing healthcare landscape has pushed the medical affairs function into roles involving clinical development, regulatory compliance and market education.

1 Jun 2015

New report on current & future trends for big data utilization in biopharmaceutical sector

In recent years, the biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights. Despite this, the inherent costs and challenges that come with utilizing Big Data have caused the biopharmaceutical sector to embrace Big Data analytics much slower than other industries.

1 Jun 2015

Merck signs in vitro fertilization deal with Genea Biomedx

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx’s product portfolio.

30 May 2015

UL, MasterControl sign collaborative agreement to support medical industry

Today, UL LLC, a global safety science organization, and MasterControl, a leading global provider of electronic quality management systems (EQMS) and quality consulting services, announce a collaborative agreement which will leverage the strengths of both organizations to support the medical industry with both quality system implementation and comprehensive advice and guidance for successful global regulatory submissions.

30 May 2015

Anything Technologies Media acquires Frontier Indoor Garden Solutions

Anything Technologies Media, Inc. has announced that it has successfully acquired Frontier Indoor Garden Solutions, Inc., a Nevada company focused on the development of commercial indoor medical cannabis facilities and outdoor industrial hemp operations throughout the United States.

29 May 2015

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.

29 May 2015

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

Zimmer Holdings, Inc. announced today that it has finalized agreements with buyers to divest in the United States certain Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow System assets and Cobalt™ bone cement assets.

29 May 2015

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

29 May 2015

For World No-Tobacco Day WHO makes a stand against illicit tobacco trade

May 31 2015 is World No Tobacco Day and the World Health Organization (WHO) is using this opportunity to bring attention to the illicit trade in tobacco and try to bring an end to it by urging Member States to sign the Protocol to Eliminate the Illicit Trade in Tobacco Products...

29 May 2015

iCo Therapeutics reports financial results for first quarter 2015

iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

29 May 2015

ESSA Pharma reports net loss of $5.9 million for second quarter 2015

ESSA Pharma Inc. today reported financial results for the second quarter and three and six months ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with International Financial Reporting Standards.

29 May 2015

ClearDATA closes $25 million Series C funding round

ClearDATA announced today the close of an over-subscribed $25 million Series C funding round with contributions from Heritage Group, HLM Venture Partners and Flare Capital Partners, along with existing investors Norwest Venture Partners, Merck Global Health Innovation Fund and Excel Venture Management.

28 May 2015

TxCell reports results from annual general meeting of shareholders

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces results of its annual general meeting of shareholders held in Valbonne, France.

28 May 2015

Novel in-line blood gas analyser demonstrated in Germany at H.I.T. 2015

The Proxima sensor is a miniaturised blood gas analyser that is integrated directly into the patient’s arterial line, which also ensures blood conservation since all blood is returned to the patient...

27 May 2015